Converge Bio
converge-bio.com
Actively hiring
Biologics & Biosimilars
Drug Discovery
Drug Discovery AI
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$5.5M
1 round on record
Latest round
$5.5M
Venture round · Nov 2024 · 22 mo ago
Team
11-50
employees, estimated range
The money's age
Due for its next round
22 months since the last round · not hiring
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 0.77%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2024 | $5.5M | — | mobihealthnews.com |
Similar startupsby what they do, their industry and backers
BigHat Biosciences designs antibodies with machine learning coupled to a fast wet laboratory. Its platform iterates designs in short…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Aqemia is a Paris company founded in 2019 that designs drug candidates with quantum-inspired statistical physics and deep learning. Its…
AI-powered gene expression models predict human tissue responses to drugs. De-risk clinical trials, optimize patient selection, and…
Antibodies Transformed. A revolutionary class of computationally designed biologics engineered to unlock challenging pathways and better…
Adaptyv Bio is a biotechnology and synthetic biology platform company headquartered in Lausanne, Switzerland. Founded in 2021 by Julian…
Financials
Total raised
$5.5M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $5.5M | Details |